ReviewAdvances in experimental medicine and biology2022
The Immunogenetics of Vasculitis.
Review in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The impact on the scientific community of the 2018 addendum to the CHCC.Frontiers in medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vasculitides are a cluster of diseases defined by an immune attack targeting vessels of different sizes. While most types of vasculitis have an undetermined cause, progress has been achieved in the recent decade in elucidating the mechanisms that participate in the inflammatory damage of the blood vessel wall. Several studies have emphasized that genetic susceptibility is an important aspect of the pathogenesis of vasculitides. The most prominent genetic risk loci for vasculitides reside within the major histocompatibility complex region. This indicates that the immune system is a major contributor to the pathogenesis of this group of diseases. In this chapter, we provide an updated overview of the etiology and pathogenesis of these entities with an emphasis on the major insights gained from recent genetic studies in the highly studied types of vasculitides.
Indexed as
Identifiers
35286700What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.